Press release
Metabolomics Market worth $4.1 billion by 2025 - Leading Key Players are Waters Corporation (US), Agilent Technologies (US), Shimadzu Corporation (Japan)
Metabolomics Market
Browse in-depth TOC on "Metabolomics Market"
299 – Tables
33 – Figures
279 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=900&utm_source=openpr&utm_medium=paidpr
The major factors driving the growth of this market are the growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, growing demand for personalized medicine and increasing use of metabolomics in toxicology testing are driving the growth of the global metabolomics industry.
Separation tools accounted for the largest share in the metabolomics market in 2019.
Based on the product & service, the market is categorized into metabolomics instruments and bioinformatics tools and services. The metabolomics instruments segment is further categorized into separation tools and detection tools. Separation tools is sub segmented into gas chromatography, high-performance liquid chromatography, ultra-performance liquid chromatography, and capillary electrophoresis. Similarly, detection tools are categorized into nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and surface-based mass analysis. The separation tools segment accounted for the largest share of the market in 2019. The widespread use of separation tools in research activities, increase in funds for research projects, development of innovative technologies in these tools, and their extensive application in the drug discovery process are fueling the growth of this segment.
Cancer accounted for the largest share in the market in 2019
Based on indication, the metabolomics market has been segmented into into cancer, cardiovascular disorders, neurological disorders, metabolic disorders, inborn errors of metabolism, and other indications. The cancer segment is expected to account for the largest market share in 2020, with the highest growth rate as well. This can primarily be attributed to the growing use of metabolomics in cancer research and increasing number of cancer patients.
Academic and research institutes accounted for the largest share the metabolomics market in 2019
Based on end user, the market has been segmented into academic and research institutes, pharmaceutical & biotechnology companies, contract research organizations, and other end users. The academic and research institutes segment accounted for the largest share of the market in 2019. The increasing number of research activities in the field of metabolomics and funding to the academic and research institutes to conduct metabolomics research are the factors responsible for the largest share of the segment.
Biomarker Discovery accounted for the largest share of the metabolomics market
Based on application, the market has been segmented into biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, personalized medicine, and other applications. Biomarker discovery accounted for the largest share of the market in 2019. The growing implications of metabolic biomarkers to access the pathophysiological health status of patients are expected to drive market growth.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=900&utm_source=openpr&utm_medium=paidpr
North America accounted for the largest share of the metabolomics market in 2019.
Based on the region, the global market is segmented into North America, Europe, the Asia Pacific, Latin Ametica and Middle East & Africa. In 2019, North America accounted for the largest share of the metabolomics technologies market. The large share of the North America region can be attributed to the presence of major players operating in the market in the US, growing biomedical research in the US, and rising preclinical activities by CROs and pharmaceutical companies in the region.
The metabolomics market is dominated by a few globally established players such as Waters Corporation (US), Agilent Technologies (US), Shimadzu Corporation (Japan), Thermo Fisher Scientific (US), Danaher Corporation (US), Bruker Corporation (US), PerkinElmer (US), Merck KGaA (Germany), GE Healthcare (US), Hitachi High-Technologies Corporation (Japan), Human Metabolome Technologies, Inc. (Japan), LECO Corporation (US), Metabolon, Inc. (US), Bio-Rad Laboratories (US), Scion Instruments (US), DANI Instruments S.p.A. (Italy), GL Sciences (Japan), SRI Instruments (US), Kore Technology Ltd. (UK), and JASCO, Inc. (US) among others.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=900&utm_source=openpr&utm_medium=paidpr
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Metabolomics Market worth $4.1 billion by 2025 - Leading Key Players are Waters Corporation (US), Agilent Technologies (US), Shimadzu Corporation (Japan) here
News-ID: 2233973 • Views: …
More Releases from MarketsandMarkets™
Feed Premix Market, Global Industry Size Forecast
The global feed premix market size is estimated to be valued at USD 24.3 billion in 2021 and is projected to reach a value of USD 32.9 billion by 2026, growing at a CAGR of 6.2% during the forecast period. The growth of this market is attributed to increasing awareness about feed quality, and the implementation of innovative animal husbandry practices to improve meat quality are the important drivers for…
Water-soluble Fertilizers Market is Expected to Grow $23.9 billion in 2028
According to a research report "Water-soluble Fertilizers Market by Type (Nitrogenous, Phosphatic, and Potassic), Mode of Application (Foliar and Fertigation), Form (Dry and Liquid), Crop Type (Field Crop, Horticulture Crops, Turf & ornaments) and Region - Global Forecast to 2028" published by MarketsandMarkets, the water-soluble fertilizers market is estimated at USD 18.3 billion in 2023 and is projected to reach USD 23.9 billion in 2028, at a CAGR of 5.5%.…
Population Health Management (PHM) Market worth $53.3 billion by 2027 - Leading …
Population Health Management (PHM) Market is projected to grow from USD 27.8 billion in 2022 to USD 53.3 billion by 2027, at a CAGR of 13.9% from 2022 to 2027, according to a new report by MarketsandMarkets™. The Growth in this market is driven by the opportunities offered by the emerging markets in healthcare. However, lack of data management, and interoperability issues are expected to challenge the growth of this…
Veterinary Pain Management Market worth $2.5 billion - Leading Key Players are B …
Veterinary Pain Management Market is projected to grow from USD 1.8 billion in 2022 to USD 2.5 billion by 2027, at a CAGR of 6.7% from 2022 to 2027, according to a new report by MarketsandMarkets™. The Pain is the physiological term to describe the chemical processes that are at work in the body that receive a stimulus, modify it, and transfer it to the brain for interpretation and reaction.…
More Releases for Metabolomics
Global metabolomics technology market, size, share and trends, analysis report b …
Orion Market Research (OMR) recently published a market research report on the global metabolomics technology market. The market is segmented on the basis of product & service and application. On the basis of product & services, the market is further segmented into metabolomics instruments and bioinformatics. Furthermore, metabolomics instruments are sub-segmented into chromatography, mass spectrometry, nuclear magnetic resonance spectroscopy, others (capillary electrophoresis, surface-based mass analysis).
Metabolomics is a study to identify…
Metabolomics Market Segmentation Analysis
A large pool of players with a robust presence points towards the high degree of competition in the global metabolomics.market Thermo Fisher, Biocrates Life Sciences, Agilent Technologies, Shimadzu, Human Metabolome Technologies, Waters, Metabolon, LECO, Bruker, and Bio-Rad Laboratories are some of the key companies leading this market, finds a new research report by Transparency Market Research (TMR).
Hitherto, these companies have relied upon innovation and product advancements for the growth of…
Global Metabolomics Market $1.4 Billion by 2021
The global metabolomics market is estimated to reach $1. 4 Billion in 2021, growing at a CAGR of 15.6% from 2017 to 2021, according to a market research report Metabolomics Market Analysis and Forecast 2017-2021, published by iHealthcareAnalyst, Inc.
The metabolomics market report estimates the market size (Revenue $million - 2014 to 2021) and key market segments based on detection and separation techniques used, its applications (biomarker discovery, clinical toxicology, drug…
Metabolomics Market: Future Demand and Growth Analysis
Metabolomics is the extensive study of small molecules, generally known as metabolites, within cells, biofluids, tissues or organisms. Together, these small molecules and their interactions in a biological system are known as the metabolome. Metabolomics involves the study of substrates and products of metabolism, which are affected by genetic and environmental factors. With the increasing applications of metabolomics in life sciences, the demand is increasing gradually. Metabolomics is gaining more…
Metabolomics Market: Overview & Sector Analysis (2016 - 2024)
Biomarker discovery segment to be the largest share of the global metabolomics market
The global metabolomics market is segmented on the basis of metabolomics instruments, application, indication, and geography. On the basis of metabolomics instrument, the metabolomics market is segmented into separation technique and detection technique. The separation technique is further segmented into gas chromatography, capillary electrophoresis, high-performance liquid chromatography, and ultra-performance liquid chromatography. The detection technique is further segmented into…
Metabolomics Market : Future of Metabolomics Dependent on Biomarker Discovery an …
According to a new market report published by Transparency Market Research “Metabolomics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2014 - 2024”, the metabolomics market is anticipated to expand at a CAGR of 17.1% from 2016 to 2024 to reach USD 2,494.8 million by 2024.
Metabolomics is the extensive study of small molecules, generally known as metabolites, within cells, biofluids, tissues or organisms. Together, these small molecules…
